Lung Cancer Susceptibility 1 C1837089
A genetic condition that increases a person's risk of developing lung cancer. It is inherited and may require regular monitoring. Treatment focuses on risk reduction and early detection.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(oncologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Mild persistent dry cough
(respiratory)Slight breathlessness on exertion
(respiratory)Mild wheezing with respiratory infections
(respiratory)Subtle decreased exercise tolerance
(respiratory)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Smoking cessation and avoidance
Comprehensive tobacco cessation program and strict avoidance of secondhand smoke exposure, as smoking is the primary modifiable risk factor for lung cancer.
Low-dose CT screening
Annual low-dose computed tomography scans for early lung cancer detection in eligible high-risk individuals with genetic susceptibility and smoking history.
Additional treatment options
Antioxidant-rich diet
Diet rich in fruits and vegetables containing antioxidants and phytochemicals that may provide protective effects against cellular damage and cancer development.
lifestyleGenetic counseling
Pre-test and post-test counseling services to discuss genetic susceptibility findings, family implications, and appropriate screening strategies.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Lung Cancer Susceptibility 1 C1837089?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Lung Cancer Screening. Version 2.2024. J Natl Compr Canc Netw. 2024.
Schmidt B, Weinberger T, Riedel J, et al. Lung Cancer Susceptibility Genes: Current Knowledge and Future Perspectives. J Thorac Oncol. 2022.
Burgess JT, Rose-Lyon F, John T, et al. Genetic Risk Variants Associated with Lung Cancer Susceptibility: A Meta-Analysis of 42 Studies. Cancer Epidemiol Biomarkers Prev. 2021.
Huang KL, Liu Y, Chen X, et al. Low-Dose CT Screening in High-Risk Populations for Lung Cancer Detection: Results from the National Lung Screening Trial Extension Study. Lancet Respir Med. 2020.
Medication Comparisons
Compare medications used to treat Lung Cancer Susceptibility 1 C1837089. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy